Taiwan Liposome Company Ltd. (NASDAQ:TLC) and Intec Pharma Ltd. (NASDAQ:NTEC) are two firms in the Biotechnology that compete against each other. Below is a comparison of their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation.
Earnings and Valuation
We can see in table 1 the earnings per share (EPS), gross revenue and valuation of Taiwan Liposome Company Ltd. and Intec Pharma Ltd.
Table 2 shows us the return on assets, net margins and return on equity of both companies.
Institutional Insider Ownership
Roughly 2.46% of Taiwan Liposome Company Ltd. shares are owned by institutional investors while 39.64% of Intec Pharma Ltd. are owned by institutional investors. Comparatively, 11.81% are Intec Pharma Ltd.’s share owned by insiders.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past